🌕 Gate Square · Creator Incentive Program Day 8 Topic– #XRP ETF Goes Live# !
Share trending topic posts, and split $5,000 in prizes! 🎁
👉 Check details & join: https://www.gate.com/campaigns/1953
💝 New users: Post for the first time and complete the interaction tasks to share $600 newcomer pool!
🔥 Day 8 Hot Topic: XRP ETF Goes Live
REX-Osprey XRP ETF (XRPR) to Launch This Week! XRPR will be the first spot ETF tracking the performance of the world’s third-largest cryptocurrency, XRP, launched by REX-Osprey (also the team behind SSK). According to Bloomberg Senior ETF Analyst Eric Balchunas,
Lilac CEO: It is expected that Lilac's new weight loss drug will be approved in early 2026
On January 13th, Jinshi Data reported that Eli Lilly CEO Dave Ricks stated that the company expects its experimental weight-loss drug to be approved as early as the beginning of 2026. Dave Ricks said in an interview that Lilly expects data on the drug, called orforglipron, to be released before mid-2025. He also said that the drug is more convenient for patients and easier to produce on a large scale.